These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2677257)

  • 1. The combined use of radiation therapy and lonidamine in the treatment of brain metastases.
    DeAngelis LM; Currie VE; Kim JH; Krol G; O'Hehir MA; Farag FM; Young CW; Posner JB
    J Neurooncol; 1989 Sep; 7(3):241-7. PubMed ID: 2677257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lonidamine in malignant brain tumors.
    Schiffer D; Sales S; Soffietti R
    Semin Oncol; 1991 Apr; 18(2 Suppl 4):38-41. PubMed ID: 2031197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of lonidamine plus radiotherapy in the treatment of brain metastases.
    Stewart DJ; Eapen L; Girard A; Verma S; Genest P; Evans WK
    J Neurooncol; 1993 Jan; 15(1):19-22. PubMed ID: 8455060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I toxicologic study of Lonidamine in cancer patients.
    Band PR; Deschamps M; Besner JG; Leclaire R; Gervais P; De Sanctis A
    Oncology; 1984; 41 Suppl 1():56-9. PubMed ID: 6717896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of lonidamine in patients with metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group Study.
    Band PR; Maroun J; Pritchard K; Stewart D; Coppin CM; Wilson K; Eisenhauer EA
    Cancer Treat Rep; 1986 Nov; 70(11):1305-10. PubMed ID: 3768873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind randomized study of lonidamine and radiotherapy in head and neck cancer.
    Magno L; Terraneo F; Bertoni F; Tordiglione M; Bardelli D; Rosignoli MT; Ciottoli GB
    Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):45-55. PubMed ID: 8175445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I trial of lonidamine with whole body hyperthermia in advanced cancer.
    Robins HI; Longo WL; Lagoni RK; Neville AJ; Hugander A; Schmitt CL; Riggs C
    Cancer Res; 1988 Nov; 48(22):6587-92. PubMed ID: 3180069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I and clinical pharmacologic evaluation of Lonidamine in patients with advanced cancer.
    Young CW; Currie VE; Kim JH; O'Hehir MA; Farag FM; Kinahan JE
    Oncology; 1984; 41 Suppl 1():60-5. PubMed ID: 6717897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity and clinical tolerance of lonidamine.
    Robustelli della Cuna G; Pedrazzoli P
    Semin Oncol; 1991 Apr; 18(2 Suppl 4):18-22. PubMed ID: 2031192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumors.
    Di Cosimo S; Ferretti G; Papaldo P; Carlini P; Fabi A; Cognetti F
    Drugs Today (Barc); 2003 Mar; 39(3):157-74. PubMed ID: 12730701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II evaluation of Lonidamine in patients with advanced malignancy.
    Evans WK; Shepherd FA; Mullis B
    Oncology; 1984; 41 Suppl 1():69-77. PubMed ID: 6717899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lonidamine in primary malignant brain tumors. Preliminary report.
    Carapella CM; Iandolo B; Delle Chiaie S; Riccio A
    Oncology; 1984; 41 Suppl 1():82-5. PubMed ID: 6717901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of Lonidamine in cancer patients.
    Band PR; Deschamps M; Besner JG; Leclaire R; Gervais P; De Sanctis A
    Oncology; 1984; 41 Suppl 1():66-8. PubMed ID: 6717898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive therapy (whole body hyperthermia versus lonidamine) to total body irradiation for the treatment of favorable B-cell neoplasms: a report of two pilot clinical trials and laboratory investigations.
    Robins HI; Longo WL; Steeves RA; Cohen JD; Schmitt CL; Neville AJ; O'Keefe S; Lagoni R; Riggs C
    Int J Radiat Oncol Biol Phys; 1990 Apr; 18(4):909-20. PubMed ID: 2182581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of lonidamine in metastatic breast cancer.
    Pronzato P; Amoroso D; Bertelli G; Conte PF; Cusimano MP; Ciottoli GB; Gulisano M; Lionetto R; Rosso R
    Br J Cancer; 1989 Feb; 59(2):251-3. PubMed ID: 2930690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase III trial with and without lonidamine in non-small cell lung cancer.
    Gatzemeier U; Cavalli F; Häussinger K; Kaukel E; Koschel G; Martinelli G; Neuhauss R; von Pawel J
    Semin Oncol; 1991 Apr; 18(2 Suppl 4):42-8. PubMed ID: 1851577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorouracil, doxorubicin, and cyclophosphamide versus fluorouracil, doxorubicin, and cyclophosphamide plus lonidamine for the treatment of advanced breast cancer: a multicentric randomized clinical study.
    Calabresi F; Di Lauro L; Marolla P; Curcio CG; Paoletti G; Calabró A; Giannarelli D; Ballatore P; Foggi CM; Di Palma M
    Semin Oncol; 1991 Apr; 18(2 Suppl 4):66-72. PubMed ID: 2031201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lonidamine alone and in combination with other chemotherapeutic agents in the treatment of cancer patients.
    Pacilio G; Carteni G; Biglietto M; De Cesare M
    Oncology; 1984; 41 Suppl 1():108-12. PubMed ID: 6326014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lonidamine versus polychemotherapy in advanced non-small-cell lung cancer. A preliminary analysis.
    Giaccone G; Bagatella M; Donadio M; Bonardi G; Maestroni F; Calciati A
    Tumori; 1989 Feb; 75(1):43-6. PubMed ID: 2540581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II double-blind randomized study of lonidamine and radiotherapy in epidermoid carcinoma of the lung.
    Privitera G; Ciottoli GB; Patanè C; Palmucci T; Tafuri G; Marletta F; De Luca B; Magnani F; De Gregorio M; Greco S
    Radiother Oncol; 1987 Dec; 10(4):285-90. PubMed ID: 3444905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.